Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
25 participants
INTERVENTIONAL
2020-03-06
2028-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MyHand: An Active Hand Orthosis for Stroke Patients
NCT03767894
Portable EMG-triggered Hand Robot for Individuals After Stroke
NCT02364700
IpsiHand System for Rehabilitation of the Arm and Hand After Stroke
NCT04123808
MyndMove Therapy for Severe Hemiparesis of the Upper Limb Following Stroke
NCT03323632
Moving a Paralyzed Hand Through Use of a Brain-Computer Interface
NCT00242242
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MyHand Treatment
Participants will use the MyHand device during repetitive grasp and release tasks.
MyHand Device
These subjects may be asked to attend 1-40 sessions (approximately 90 mins) to trial a variety of device controls and/or components.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MyHand Device
These subjects may be asked to attend 1-40 sessions (approximately 90 mins) to trial a variety of device controls and/or components.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* History of stroke(s) with most recent stroke at least six months ago
* Upper extremity weakness with impaired ability to complete daily activities with affected hand
* Full passive range of motion in all digits
* Intact cognition to follow directions
* Gross control of proximal upper extremity musculature
Exclusion Criteria
* Other orthopedic conditions to affected upper extremity
* Significant spasticity in affected upper extremity that impairs device fit
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Columbia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joel Stein, MD
Professor and Chair of the Department of Rehabilitation and Regenerative Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joel Stein
Role: PRINCIPAL_INVESTIGATOR
Columbia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Columbia University Irving Medical Center
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Joel Stein, MD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAAS8104
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.